Literature DB >> 31758529

Co-signal Molecules in T-Cell Activation : Historical Overview and Perspective.

Miyuki Azuma1.   

Abstract

The two-signal model of T-cell activation, proposed approximately four decades ago, has undergone various refinements while maintaining its principal doctrine. Since the discovery of CD28, a variety of co-signal molecules, including co-stimulatory and co-inhibitory receptors and ligands, have been identified. These molecules fine-tune various immune responses both in the primary or secondary lymphoid tissues and in the peripheral tissues. Most co-signal receptors are expressed and induced on T cells during distinct stages (naïve/resting, activating, memory, and exhausting). These co-signaling pathways play critical and diverse roles in maintaining T-cell tolerance and eliciting T-cell immune responses in health and disease. This introductory chapter provides a historical overview of the key findings that have led to our current view of T-cell co-stimulation.

Entities:  

Keywords:  Co-inhibition; Co-signals; Co-stimulation; T-cell activation; Tolerance; Two-signal model

Mesh:

Substances:

Year:  2019        PMID: 31758529     DOI: 10.1007/978-981-32-9717-3_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

Review 1.  Nanomedicines in B cell-targeting therapies.

Authors:  Jiawei Wang; Jiyuan Yang; Jindřich Kopeček
Journal:  Acta Biomater       Date:  2021-10-21       Impact factor: 8.947

2.  T cell co-stimulator inducible co-stimulatory (ICOS) exerts potential anti-atherosclerotic roles through downregulation of vascular smooth muscle phagocytosis and proliferation.

Authors:  Zhixiong Zhong; Qunji Zhang; Linkai Tan; Xuemin Guo; Caiyan Gan
Journal:  Ann Transl Med       Date:  2020-12

Review 3.  Overcoming the challenges associated with CD3+ T-cell redirection in cancer.

Authors:  Ajit Singh; Sundee Dees; Iqbal S Grewal
Journal:  Br J Cancer       Date:  2021-01-19       Impact factor: 7.640

4.  The Transcriptional Differences of Avian CD4+CD8+ Double-Positive T Cells and CD8+ T Cells From Peripheral Blood of ALV-J Infected Chickens Revealed by Smart-Seq2.

Authors:  Manman Dai; Li Zhao; Ziwei Li; Xiaobo Li; Bowen You; Sufang Zhu; Ming Liao
Journal:  Front Cell Infect Microbiol       Date:  2021-11-10       Impact factor: 5.293

Review 5.  Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers.

Authors:  Aaron J Harrison; Xin Du; Bianca von Scheidt; Michael H Kershaw; Clare Y Slaney
Journal:  Immunother Adv       Date:  2021-07-31

Review 6.  T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities.

Authors:  Patrick A Baeuerle; Holger Wesche
Journal:  Curr Opin Oncol       Date:  2022-07-28       Impact factor: 3.915

7.  Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer.

Authors:  Pan Yuefen; Han Shuwen; Shen Junjun; Wang Yangyanqiu; Zhuang Jing; Pu Jie; Chu Jian
Journal:  Breast Cancer       Date:  2022-03-01       Impact factor: 3.307

Review 8.  T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors.

Authors:  Nicholas J Chandler; Melissa J Call; Matthew E Call
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

Review 9.  Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus.

Authors:  Volker Schirrmacher
Journal:  Biomedicines       Date:  2022-02-28

10.  Overexpression of PD-L1 in gingival basal keratinocytes reduces periodontal inflammation in a ligature-induced periodontitis model.

Authors:  Keeratika Wongtim; Eri Ikeda; Tatsukuni Ohno; Shigenori Nagai; Shigeru Okuhara; Keitetsu Kure; Miyuki Azuma
Journal:  J Periodontol       Date:  2021-06-05       Impact factor: 4.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.